$1.18B
$691,000
0.0% of portfolio
34,844
Q2 2024
Reduced 73.2%
$3.91B
$964,000
0.0% of portfolio
15,292
Q4 2024
Reduced 5.58%
$2.95B
$504,000
0.0% of portfolio
31,009
Q2 2024
Reduced 8.82%
$1.85B
$364,000
0.0% of portfolio
10,983
Q3 2024
Reduced 9.98%
$4.35B
$404,000
0.0% of portfolio
3,553
Q4 2024
Reduced 2.47%
$1.86B
$570,000
0.0% of portfolio
19,420
Q4 2024
Reduced 13.99%
$249M
$94,000
0.0% of portfolio
11,974
Q2 2024
Added 11.24%
$7.3B
$1.05 Million
0.0% of portfolio
47,680
Q1 2025
Added 3.81%
$284M
$217,000
0.0% of portfolio
65,451
Q2 2024
Added 35.48%
$3.44B
$1.96 Million
0.0% of portfolio
31,117
Q2 2024
Reduced 16.77%
$4.36B
$951,000
0.0% of portfolio
9,087
Q4 2024
Reduced 1.09%
$3.33B
$2.4 Million
0.0% of portfolio
87,746
Q1 2025
Added 2.56%
$87.3M
$429,000
0.0% of portfolio
292,445
Q1 2025
Added 558.75%
$5.39B
$1.22 Million
0.0% of portfolio
11,666
Q4 2024
Reduced 1.35%
$6.94B
$1.19 Million
0.0% of portfolio
14,150
Q4 2024
Reduced 6.04%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 8.62%
$219M
$44,000
0.0% of portfolio
10,569
Q2 2024
New
$1.27B
$242,000
0.0% of portfolio
19,951
Q2 2024
Reduced 42.44%
$1.17B
$174,000
0.0% of portfolio
24,250
Q2 2024
New
$1.03B
$213,000
0.0% of portfolio
7,890
Q2 2024
New
$2B
$513,000
0.0% of portfolio
31,886
Q2 2024
Reduced 75.82%
$4.01B
$700,000
0.0% of portfolio
5,565
Q1 2025
Added 11.86%
$326M
$145,000
0.0% of portfolio
24,312
Q2 2024
Added 29.17%
$1.58B
$612,000
0.0% of portfolio
127,154
Q2 2024
Reduced 67.53%
$4.59B
$479,000
0.0% of portfolio
79,580
Q2 2024
Added 168.04%
$3.77B
$456,000
0.0% of portfolio
1,355
Q4 2024
Reduced 2.17%
$295M
$45,000
0.0% of portfolio
24,390
Q3 2024
New
$4.53B
$1.21 Million
0.0% of portfolio
20,757
Q1 2025
Reduced 11.51%
$404M
$202,000
0.0% of portfolio
32,308
Q2 2024
Added 0.06%
$1.78B
$2.34 Million
0.0% of portfolio
109,852
Q4 2024
Added 2.97%
$890M
$296,000
0.0% of portfolio
34,174
Q2 2024
Reduced 44.45%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.59%
$869M
$267,000
0.0% of portfolio
5,473
Q4 2024
Reduced 74.75%
$1.98B
$251,000
0.0% of portfolio
4,840
Q2 2024
New
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q1 2025
New
$4.8B
$1.39 Million
0.0% of portfolio
62,179
Q2 2024
Reduced 11.55%
$623M
$181,000
0.0% of portfolio
16,821
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
$1.51B
$390,000
0.0% of portfolio
25,666
Q2 2024
Reduced 27.12%
$1B
$1.11 Million
0.0% of portfolio
135,833
Q4 2024
Reduced 5.53%
$3.77B
$945,000
0.0% of portfolio
14,743
Q1 2025
Reduced 0.09%
$3.69B
$1.39 Million
0.0% of portfolio
20,541
Q2 2024
Added 10.49%
$802M
$297,000
0.0% of portfolio
130,370
Q2 2024
Added 3.0%
$5.08B
$1.06 Million
0.0% of portfolio
35,768
Q2 2024
Reduced 27.28%
$489M
$123,000
0.0% of portfolio
25,000
Q2 2024
New
$747M
$138,000
0.0% of portfolio
18,507
Q2 2024
Added 0.27%
$3.4B
$1.05 Million
0.0% of portfolio
5,807
Q4 2024
Reduced 1.02%
$1.91B
$523,000
0.0% of portfolio
15,873
Q3 2024
Reduced 73.15%
$439M
$149,000
0.0% of portfolio
22,684
Q2 2024
Added 0.76%
$2.61B
$335,000
0.0% of portfolio
12,245
Q2 2024
Reduced 3.16%